BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 9289667)

  • 1. [Hormonal contraception and benign breast disease. Evaluation of a treatment protocol for chronic mastopathy with mastalgia].
    Leonardi M
    Minerva Ginecol; 1997 Jun; 49(6):271-6. PubMed ID: 9289667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of fibrocystic disease of the breast with myrtillus anthocyanins. Our experience].
    Leonardi M
    Minerva Ginecol; 1993 Dec; 45(12):617-21. PubMed ID: 8139788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclical mastalgia and breast pathology.
    Jørgensen J; Watt-Boolsen S
    Acta Chir Scand; 1985; 151(4):319-21. PubMed ID: 4041107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral contraception and breast pathology.
    Ragni N; Boccardo E; Viglino S; Larosa E
    Acta Eur Fertil; 1981 Jun; 12(2):141-63. PubMed ID: 6794288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrocystic breast disease: pathophysiology, pathomorphology, clinical picture, and management.
    Vorherr H
    Am J Obstet Gynecol; 1986 Jan; 154(1):161-79. PubMed ID: 3511705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. THE ROLE OF E2/P RATIO IN THE ETIOLOGY OF FIBROCYSTIC BREAST DISEASE, MASTALGIA AND MASTODYNIA.
    Brkić M; Vujović S; Ivović M; Tančić Gajić M; Marina L; Franić Ivanišević M; Franić D
    Acta Clin Croat; 2018 Dec; 57(4):756-761. PubMed ID: 31168213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrocystic disease of the breast.
    Greenblatt RB; Samaras C; Vasquez JM; Nezhat C
    Clin Obstet Gynecol; 1982 Jun; 25(2):365-71. PubMed ID: 7105513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The "luteal breast": hormonal and sonographic investigation of benign breast disease in patients with cyclic mastalgia.
    Ayers JW; Gidwani GP
    Fertil Steril; 1983 Dec; 40(6):779-84. PubMed ID: 6653797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of alpha dihydroergocryptine in patients with fibrocystic breast disease].
    Castillo E; Garibay M; Mirabent F
    Ginecol Obstet Mex; 2006 Nov; 74(11):580-4. PubMed ID: 17357577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mastalgia: a review of management.
    Olawaiye A; Withiam-Leitch M; Danakas G; Kahn K
    J Reprod Med; 2005 Dec; 50(12):933-9. PubMed ID: 16444894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical determinants of mammographic dysplasia patterns.
    Deschamps M; Band PR; Coldman AJ; Hislop TG; Longley DJ
    Cancer Detect Prev; 1996; 20(6):610-9. PubMed ID: 8939347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of 1294 Female Patients with Breast Pain: A Retrospective Study.
    Altıntas Y; Bayrak M
    Adv Ther; 2018 Sep; 35(9):1411-1419. PubMed ID: 30094702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ultrasonography in the diagnosis of diffuse fibrocystic mastopathy].
    Trofimova TN; Solntseva IA
    Vestn Rentgenol Radiol; 1999; (4):17-20. PubMed ID: 11082686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Danol (danazol) in the treatment of fibrocystic breast disease with mastodynia].
    Lorenz I
    Cas Lek Cesk; 1989 Feb; 128(7):209-11. PubMed ID: 2720755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous hormone use and fibrocystic breast disease by histopathologic component.
    Berkowitz GS; Kelsey JL; LiVolsi VA; Merino MJ; Holford TR; Hildreth NG; Ort S; O'Connor TZ; White C
    Int J Cancer; 1984 Oct; 34(4):443-9. PubMed ID: 6490201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benign breast disease and the risk of breast cancer in the next 15 years.
    Socolov D; Anghelache I; Ilea C; Socolov R; Carauleanu A
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(1):135-40. PubMed ID: 25970956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective Analysis of Women with Only Mastalgia.
    Arslan M; Küçükerdem HS; Can H; Tarcan E
    J Breast Health; 2016 Oct; 12(4):151-154. PubMed ID: 28331753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical comparision of alpha dihydroergocryptine against cabergoline in the treatment of the fibrocystic mastopathy].
    Castillo-Huerta E; Garibay-Valencia M; Mirabent-González F
    Ginecol Obstet Mex; 2013 Jul; 81(7):370-6. PubMed ID: 23971383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic progestin therapy for the management of mastopathy and mastodynia.
    Winkler UH; Schindler AE; Brinkmann US; Ebert C; Oberhoff C
    Gynecol Endocrinol; 2001 Dec; 15 Suppl 6():37-43. PubMed ID: 12227885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fibrocystic mastopathy and cancer of the breast. About 111 cases].
    Beyrouti MI; Beyrouti R; Khabir A; Ben Amar M; Frikha F; Dhieb N; Damak D; Abid M; Affes N; Boujelben S; Frikha M
    Tunis Med; 2006 Oct; 84(10):626-31. PubMed ID: 17193854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.